Effects of repeated dosing with Udenafil (Zydena) on cognition, somatization and erection in patients with erectile dysfunction: A pilot study

International Journal of Impotence Research

Volumn 23, Issue 3, 2011, Pages 109-114

  Shim, Y S ^a   Pae, C U ^a   Kim, S W ^b   Kim, H W ^c   Kim, J C ^a   Koh, J S ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

cognition; erectile dysfunction; PDE5 inhibitor; somatization disorder

Indexed keywords

UDENAFIL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; DRUG EFFICACY; ERECTILE DYSFUNCTION; HUMAN; LEARNING TEST; MALE; MINI MENTAL STATE EXAMINATION; PENIS ERECTION; PILOT STUDY; PRIORITY JOURNAL; SOMATIZATION;

ADULT; AGED; COGNITION; ERECTILE DYSFUNCTION; HUMANS; MALE; MIDDLE AGED; PHOSPHODIESTERASE 5 INHIBITORS; PROSPECTIVE STUDIES; PYRIMIDINES; SEVERITY OF ILLNESS INDEX; SOMATOFORM DISORDERS; SULFONAMIDES;

EID: 79959268066     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/ijir.2011.13     Document Type: Article

References (30)

1. Ballard SA, Gingell CJ, Tang K, Turner LA, Price ME, Naylor AM. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J Urol 1998; 159: 2164-2171. (Pubitemid 29190800)
2. Rosen RC, Kostis JB. Overview of phosphodiesterase 5 inhibition in erectile dysfunction. Am J Cardiol 2003; 92: 9M-18M. (Pubitemid 37386271)
3. Salem EA, Kendirci M, Hellstrom WJ. Udenafil, a long-acting PDE5 inhibitor for erectile dysfunction. Curr Opin Investig Drugs 2006; 7: 661-669. (Pubitemid 44018351)
4. Paick JS, Kim SW, Yang DY, Kim JJ, Lee SW, Ahn TY, et al. The efficacy and safety of udenafil, a new selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction. J Sex Med 2008; 5: 946-953. (Pubitemid 351472204)
5. Stehlik J, Movsesian MA. Combined use of PDE5 inhibitors and nitrates in the treatment of pulmonary arterial hypertension in patients with heart failure. J Card fail 2009; 15: 31-34.
6. Giannitsas K, Mitropoulos D, Konstantinopoulos A, Athanasopoulos A, Perimenis P. Phosphodiesterase-5 inhibitors in the treatment of lower urinary tract symptoms and benign prostatic hyperplasia. Expert Opin Pharmacother 2008; 9: 1687-1693.
7. Bednar MM. The role of sildenafil in the treatment of stroke. Curr Opin Investig Drugs 2008; 9: 754-759. (Pubitemid 351950872)
8. van Staveren WC, Markerink-van Ittersum M. Localization of cyclic guanosine 30,50-monophosphate-hydrolyzing phosphodiesterase type 9 in rat brain by nonradioactive in situ hybridization. Methods Mol Biol 2005; 307: 75-84.
9. Zhang R, Wang Y, Zhang L, Zhang Z, Tsang W, Lu M, et al. Sildenafil (Viagra) induces neurogenesis and promotes functional recovery after stroke in rats. Stroke 2002; 33: 2675-2680. (Pubitemid 35266440)
10. Erceg S, Monfort P, Hernández-Viadel M, Rodrigo R, Montoliu C, Felipo V. Oral administration of sildenafil restores learning ability in rats with hyperammonemia and with portacaval shunts. Hepatology 2005; 41: 299-306. (Pubitemid 40165373)
11. Prickaerts J, de Vente J, Honig W, Steinbusch HW, Blokland A. cGMP, but not cAMP, in rat hippocampus is involved in early stages of object memory consolidation. Eur J Pharmacol 2002; 436: 83-87. (Pubitemid 34142401)
12. Yamada K, Hiramatsu M, Noda Y, Mamiya T, Murai M, Kameyama T, et al. Role of nitric oxide and cyclic GMP in the dizocilpine-induced impairment of spontaneous alternation behavior in mice. Neuroscience 1996; 74: 365-374. (Pubitemid 26274208)
13. Prickaerts J, van Staveren WC, Sik A, Markerink-van Ittersum M, Niewöhner U, van der Staay FJ, et al. Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and vardenafil, on object recognition memory and hippocampal cyclic GMP levels in the rat. Neuroscience 2002; 113: 351-361. (Pubitemid 34786180)
14. Patil CS, Singh VP, Kulkarni SK. Modulatory effect of sildenafil in diabetes and electroconvulsive shock-induced cognitive dysfunction in rats. Pharmacol Rep 2006; 58: 373-380. (Pubitemid 44111072)
15. Devan BD, Pistell PJ, Daffin Jr LW, Nelson CM, Duffy KB, Bowker JL, et al. Sildenafil citrate attenuates a complex maze impairment induced by intracerebroventricular infusion of the NOS inhibitor Nomega-nitro-L-arginine methyl ester. Eur J Pharmacol 2007; 563: 134-140. (Pubitemid 46628798)
16. Goff DC, Cather C, Freudenreich O, Henderson DC, Evins AE, Culhane MA, et al. A placebo-controlled study of sildenafil effects on cognition in schizophrenia. Psychopharmacology (Berl) 2009; 202: 411-417.
17. Corporate author: NIH. NIH Consensus Conference. NIH consensus development panel on impotence. JAMA 1993; 270: 83-90.
18. Rhoden EL, Telöken C, Sogari PR, Vargas Souto CA. The use of the simplified international index of erectile function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction. Int J Impot Res 2002; 14: 245-250. (Pubitemid 34947727)
19. Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002; 64: 258-266. (Pubitemid 34260463)
20. Interian A, Allen LA, Gara MA, Escobar JI, Diaz-Martinez AM. Somatic complaints in primary care: further examining the validity of the Patient Health Questionnaire (PHQ-15). Psychosomatics 2006; 47: 392-398.
21. Jeong SK, Cho KH, Kim JM. The usefulness of the Korean version of modified Mini-Mental State Examination (K-mMMSE) for dementia screening in community dwelling elderly people. BMC Public health 2004; 4: 31.
22. Chey J, Kim JW, Cho HY. Hormone replacement therapy in postmenopausal women with Alzheimer0s disease: a randomized, prospective study. Neurosci Lett 2000; 289: 230-234.
23. Kim TH, Huh Y, Choe JY, Jeong JW, Park JH, Lee SB, et al. Korean version of frontal assessment battery: psychometric properties and normative data. Dement Geriatr Cogn Disord 2010; 29: 363-370.
24. Hogervorst E, Combrinck M, Lapuerta P, Rue J, Swales K, Budge M. The Hopkins verbal learning test and screening for dementia. Dement Geriatr Cogn Disord 2002; 13: 13-20. (Pubitemid 33153183)
25. Rutten K, Van Donkelaar EL, Ferrington L, Blokland A, Bollen E, Steinbusch HW, et al. Phosphodiesterase inhibitors enhance object memory independent of cerebral blood flow and glucose utilization in rats. Neuropsychopharmacology 2009; 34: 1914-1925.
26. Arnavaz A, Aurich A, Weissenborn K, Hartmann U, Emrich HM, Schneider U. Effect of sildenafil (Viagra) on cerebral blood flow velocity: a pilot study. Psychiatry Res 2003; 122: 207-209. (Pubitemid 36412196)
27. Hatzichristou D, Cuzin B, Martin-Morales A, Buvat J, Porst H, Laferriere N. Vardenafil improves satisfaction rates, depressive symptomatology, and self-confidence in a broad population of men with erectile dysfunction. J Sex Med 2005; 2: 109-116. (Pubitemid 40468198)
28. Rosen R, Shabsigh R, Berber M, Assalian P, Menza M, Rodriguez-Vela L. Efficacy and tolerability of vardenafil in men with mild depression and erectile dysfunction: the depression-related improvement with vardenafil for erectile response study. Am J Psychiatry 2006; 163: 79-87. (Pubitemid 43050107)
29. Christensen H, Griffiths K, Mackinnon A, Jacomb P. A quantitative review of cognitive deficits in depression and Alzheimer-type dementia. J Int Neuropsychol Soc 1997; 3: 631-651. (Pubitemid 27510846)
30. Althof SE, Berner MM, Goldstein I, Claes HI, Cappelleri JC, Bushmakin AG, et al. Interrelationship of sildenafil treatment effects on the physiological and psychosocial aspects of erectile dysfunction of mixed or organic etiology. J Sex Med 2010; 7: 3170-3178.